HUMANA INC (HUM) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:HUM - US4448591028 - Common Stock
HUM Key Statistics, Chart & Performance
The current stock price of HUM is 279.84 USD. In the past month the price increased by 8.53%. In the past year, price increased by 4.01%.
HUM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 16.61 | 316.11B | ||
| ELV | ELEVANCE HEALTH INC | 12.1 | 82.53B | ||
| CNC | CENTENE CORP | 11.32 | 22.48B | ||
| MOH | MOLINA HEALTHCARE INC | 10.01 | 9.50B | ||
| HQY | HEALTHEQUITY INC | 25.45 | 8.16B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 4.26B | ||
| PGNY | PROGYNY INC | 42.33 | 2.30B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.34B |
Related stock screener links
About HUM
Company Profile
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 65,680 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
Company Info
HUMANA INC
500 W Main St
Louisville KENTUCKY 40202 US
CEO: Bruce D. Broussard
Employees: 65680
Phone: 15025801000
HUMANA INC / HUM FAQ
What does HUM do?
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 65,680 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
What is the current price of HUM stock?
The current stock price of HUM is 279.84 USD. The price increased by 1.46% in the last trading session.
Does HUM stock pay dividends?
HUMANA INC (HUM) has a dividend yield of 1.38%. The yearly dividend amount is currently 3.55.
What is the ChartMill technical and fundamental rating of HUM stock?
HUM has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is HUMANA INC (HUM) stock traded?
HUM stock is listed on the New York Stock Exchange exchange.
How is the market expecting HUM stock to perform?
32 analysts have analysed HUM and the average price target is 294.2 USD. This implies a price increase of 5.13% is expected in the next year compared to the current price of 279.84.
Can you provide the upcoming earnings date for HUMANA INC?
HUMANA INC (HUM) will report earnings on 2026-02-09, after the market close.
HUM Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to HUM. When comparing the yearly performance of all stocks, HUM turns out to be only a medium performer in the overall market: it outperformed 44.25% of all stocks.
HUM Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to HUM. There are concerns on the financial health of HUM while its profitability can be described as average.
HUM Financial Highlights
Over the last trailing twelve months HUM reported a non-GAAP Earnings per Share(EPS) of 18.93. The EPS increased by 3.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.02% | ||
| ROA | 2.6% | ||
| ROE | 6.97% | ||
| Debt/Equity | 0.68 |
HUM Forecast & Estimates
32 analysts have analysed HUM and the average price target is 294.2 USD. This implies a price increase of 5.13% is expected in the next year compared to the current price of 279.84.
For the next year, analysts expect an EPS growth of 6.41% and a revenue growth 10.4% for HUM